Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.
Igyxos has raised $6.7M in total funding. The most recent round was Grant. The last funding was announced in October 2025.
Igyxos's investors include Bpifrance, GO CAPITAL, France 2030, Sofimac Innovation.
Igyxos is headquartered in Nouzilly, France.
Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.
Igyxos is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Igyxos — Funding & Investors." VCBacked, October 2, 2025, https://www.vcbacked.co/company/igyxos. Accessed October 9, 2026.
VCBacked. (2025). Igyxos — Funding & Investors. Retrieved October 9, 2026, from https://www.vcbacked.co/company/igyxos
{{cite web |title=Igyxos — Funding & Investors |url=https://www.vcbacked.co/company/igyxos |website=VCBacked |access-date=October 9, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated